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The Impact of a Managed Care Obesity Intervention on Clinical
Outcomes and Costs: A Prospective Observational Study
Amy E. Rothberg1, Laura N. McEwen1, Tom Fraser2, Charles F. Burant1 and William H. Herman1,2,3
Objective: To evaluate the impact of a managed care obesity intervention that requires enrollment in an
intensive medical weight management program, a commercial weight loss program, or a commercial
pedometer-based walking program to maintain enhanced benefits.
Design and Methods: Prospective observational study involving 1,138 adults with BMI32 kg m22 with
one or more comorbidities or BMI 35 kg m22 enrolled in a commercial, independent practice
association-model health maintenance organization. Body mass index, blood pressure, lipids, HbA1c or
fasting glucose, and per-member per-month costs were assessed 1 year before and 1 year after program
implementation.
Results: Program uptake (90%) and 1 year adherence (79%) were excellent. Enrollees in all three pro-
grams exhibited improved clinical outcomes and reduced rates of increase in direct medical costs com-
pared to members who did not enroll in any program.
Conclusions: A managed care obesity intervention that offered financial incentives for participation and
a variety of programs was associated with excellent program uptake and adherence, improvements in
cardiovascular risk factors, and a lower rate of increase in direct medical costs over 1 year.
Obesity (2013) 21, 2157–2162. doi:10.1002/oby.20597
Introduction
Between 1980 and 2004, the prevalence of obesity doubled among
US adults (1). Approximately 33% of US adults are overweight
(body mass index (BMI) 25.0-29.9 kg m22), 28% are obese (BMI
30.0-39.9 kg m22), and nearly 6% are extremely obese (BMI 40.0
kg m22) (1). Similarly, more than half of all US adults do not get
adequate physical activity and approximately one-quarter do not get
any leisure-time physical activity (1). Being overweight or obese
and sedentary increase the risk for many chronic conditions includ-
ing stroke, heart disease, hypertension, dyslipidemia, insulin resist-
ance, type 2 diabetes, and depression.
Both obesity and sedentary lifestyle are also associated with
increased medical spending. In 2008, 9.1% of all medical spending
in the US, an estimated $147 billion, was attributed to obesity (2). It
has been estimated that if 10% of US adults began regular walking
programs, heart disease costs could be reduced by nearly $6 billion
(1). Reversing the US epidemic of obesity and sedentary lifestyle
and their attendant costs will require innovative approaches to sup-
port and promote healthy lifestyle choices (3).
When implemented within organized systems of health care, weight
loss and physical activity programs have an enormous potential to
improve clinical outcomes. Managed care organizations can use
information systems to target interventions to patients who need
them and can modify benefit structures or provide financial incen-
tives to encourage participation. In managed care organizations,
patients have access to primary care, laboratory testing, and medica-
tions. Because managed care organizations pay all direct medical
costs (and track co-payments), managed care data can be used to
assess return-on-investment. In addition, because managed care
organizations are ultimately businesses, a “business case” can be
made for effective and cost-effective disease management strategies
to ensure their sustainability.
Although expensive, medical weight management programs have
been shown to be effective for weight loss. The University of Michi-
gan Weight Management Program is a 2-year program that employs
intensive energy restriction for the first 12 weeks to promote 15%
weight loss, followed by interventions to support behavior change
and promote regular physical activity. Prior to enrollment, patients
are asked to attend an orientation session that reviews the scope of
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the obesity problem, the epidemiology and biology of obesity, and
the requirements of the program. Patients who elect to enroll must
sign a contract agreeing to attend >80% of their scheduled appoint-
ments. Patients are seen by a physician for an initial assessment, at 1
month, and quarterly thereafter. Patients are seen weekly by a dieti-
tian during the first month, twice monthly for the next 2 months, and
monthly thereafter. The initial 12 weeks of the program employs a
very low calorie diet (VLCD, 800 kcal day21) in the form of total
meal replacement (800 solutions, HMRVR , Boston, MA). Over the first
12 weeks of the program, patients are also asked to gradually increase
their physical activity (low to moderate intensity) to 40 min day21.
Patients are asked to keep diaries to record the number of meal
replacement shakes consumed per day and any deviations from the
prescribed diet, their feelings of hunger and satiety, and their physical
activity. These diaries are reviewed each week with the dietitian
either in person, by telephone, or by e-mail. Following the initial
weight loss with VLCD, patients are transitioned to regular food
stuffs. An exercise physiologist is available to provide a one-time, 1-
h, exercise consultation to develop an activity program that incorpo-
rates patient preferences. Participants are subsequently asked to per-
form 40-90 min of moderate to vigorous physical activity per day.
Less intensive, commercial medical weight management programs
have also been shown to be effective for weight loss. In a random-
ized controlled clinical trial, Dansinger et al. assessed adherence
rates and the effectiveness of four popular diets for weight loss and
cardiac risk factor reduction (4). These included Weight Watchers,
and the Atkins, Zone, and Ornish diets. At 1 year, continuation rates
tended to be higher for the more moderate diets (65% for Weight
Watchers and Zone) and lower for the more extreme diets (52% for
Atkins and 50% for Ornish). Each diet modestly reduced body
weight and several cardiac risk factors at 1 year. In general, greater
effects were observed in study completers. A systematic review that
described the effectiveness and cost of major commercial weight
loss programs that provide structured in-person or online counseling
cited three randomized controlled trials of Weight Watchers, the
largest of which reported a loss of 3.2% of initial weight at 2 years
(5). Internet-based interventions and organized self-help programs
produced minimal weight loss (5).
There are also a number of commercial pedometer-based walking
programs that use dual axial accelerometer mechanism pedometers.
WalkingSpree is one such program that incorporates pedometers
with web-based interfaces to assess activity, food consumption, and
body weight, and to support social networking. The literature evalu-
ating the impact of commercial physical activity intervention pro-
grams on fitness is limited and the outcomes are largely predicated
on subject selection. Motivated patients who adhere to intervention
programs are much more likely to be successful (6). Cross-sectional
observational studies have shown that people who walk more tend
to be more fit and thinner than those who walk less (7). In a recent
systematic review, the most important participant characteristics
associated with increased physical activity were younger age and
lower baseline physical activity (8). The intervention characteristics
most strongly associated with increased physical activity were hav-
ing a step goal and requiring participants to use a step diary (8).
Beginning in November 2006, Blue Care Network (BCN), the largest
health management organization in Michigan, collaborated with its
employer groups to offer Healthy Blue Living (HBL), a commercial
health insurance product that includes strong incentives for patients,
providers, and employers to work towards improved health in six
high-impact areas including obesity. Under Michigan state law, insur-
ance benefits cannot be predicated on health outcomes but can be
based on processes of care. Members who participate in HBL must
complete a HBL Qualification Form, commit to maintain or adopt a
healthy lifestyle, and work to achieve their wellness plan. Members
who adhere to HBL program requirements receive additional benefits
and reduced copayments for office, urgent care, and emergency room
visits and for prescription drugs. Those who do not adhere to the pro-
gram requirements revert to standard benefits. The difference in out-
of-pockets costs between HBL enhanced and standard benefits is
$800 per member per year. The HBL program compensates pro-
viders for their participation and offers a 10% reduction in premiums
to employers for their employees who elect HBL. Providers who par-
ticipate in HBL agree to validate all patient-reported information on
the HBL Qualification Forms and to schedule follow-up appointments
as needed. Employers who offer HBL are required to support the
goals of the program. Since its introduction, HBL has had the largest
uptake of any commercial program offered by BCN.
In 2006, HBL Qualification Forms indicated that one-third of mem-
bers were overweight or obese. Despite patients’ commitment to
actively participate in physician-supervised weight loss interven-
tions, analyses of HBL Qualification Forms from 2006 to 2009 indi-
cated no progress with respect to weight management. Additional
analyses demonstrated that obese members incurred consistently
higher per capita medical costs than normal weight members. Com-
pared to members without obesity, members with obesity incurred
31% higher annual per capita medical costs. Obese members with
diabetes incurred average annual per capita medical costs nearly
175% higher than members without obesity and diabetes.
In 2009, BCN elected to require participation in either Weight
Watchers or WalkingSpree for HBL members with BMI 30 kg
m22 in order for them to maintain enhanced benefits. A subgroup of
members with BMI 32 kg m22 with one or more comorbidities or
BMI 35 kg m22 who lived in southeastern Michigan and worked
for employer groups that agreed to offer the program was also
offered the opportunity to enroll in the University of Michigan
Weight Management Program (WMP). All programs were offered to
eligible members with no out-of-pocket costs except that members
had to pay the cost of meal replacements in the WMP, which was
$805 for 12 weeks. The goal of this study was to evaluate the
impact of a benefit structure and financial incentives that encour-
aged participation in these weight management programs on body
mass index (BMI) and direct medical costs; as well as blood pres-
sure, lipids, and measures of glycemia, and to perform a rigorous
cost-benefit analysis of the program.
Methods
The study was reviewed and approved by the University of Michi-
gan Institutional Review Board. Using HBL Qualification Forms,
we identified all adult members with BMI 30 kg m22. In this anal-
ysis, we studied the subgroup of adult HBL members who had BMI
32 kg m22 with one or more comorbidities or BMI 35 kg m22
who lived in southeastern Michigan and who were enrolled in
employer groups that agreed to offer the WMP, Weight Watchers,
and WalkingSpree to members between January 1, 2010 and
December 20, 2012. We included all members who were eligible to
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participate in the three programs and who were sent notification let-
ters to join the WMP, Weight Watchers, or WalkingSpree. We then
classified them according to the program in which they first enrolled
(WMP, Weight Watchers, WalkingSpree, none).
For each member, we determined an anchor date. For members who
enrolled in a weight management program, this was the date of first
enrollment after the notification letter was sent. For members who
did not enroll in a program, the anchor date was defined as the date
the notification letter was sent plus the mode number of days to
enrollment for those who enrolled in a weight management program.
Members were then assigned to cohorts based on their initial pro-
gram selection. Demographic and clinical data were collected from
HBL enrollment forms completed immediately before and 12
months after the anchor date. Utilization data were also summarized
for the time period 12 months before and 12 months after the anchor
date. Member paid amounts and plan paid amounts (using standard
costs across provider groups and hospitals) were summarized for
services received during each time interval. Costs were categorized
into seven mutually exclusive bins including inpatient medical, out-
patient medical, emergency room, diagnostic testing, laboratory test-
ing, pharmacy, and other.
Per-member per-month (PMPM) costs of the WMP, Weight Watch-
ers, and WalkingSpree were added to the “other” cost category for
each participant according to the program in which they enrolled
and their duration of enrollment. Because we adopted a health sys-
tem perspective and considered only direct medical costs and
because all members paid for their own food (including meal
replacements), we did not include the cost of meal replacements in
the cost of the WMP. Based upon the published retail cost of meal
replacement shakes and US Department of Agriculture estimates of
daily per capita costs of food eaten at home and away from home,
the average daily cost of meal replacements and regular food stuffs
was comparable ($9.58 per day vs. $11.59 per day, respectively).
Analyses were performed for the total population and for the subsets
of individuals who remained enrolled in the WMP, Weight Watch-
ers, or WalkingSpree for the entire 12 month follow-up period. To
compare risk factor levels and costs before enrollment and 12
months after enrollment, we performed paired t tests. Because of the
short time horizon of our study (2 years), we did not perform dis-
counting. Analyses were performed using SAS version 9.1 (SAS
Institute, Cary, NC). Results are expressed as mean6 standard devi-
ation or as percent.
Results
There were 1,138 HBL members with BMI 32 kg m22 and one or
more comorbidities, or BMI 35 kg m22, who met eligibility
requirements and were invited to participate in the University of
Michigan Weight Management Program (WMP), Weight Watchers,
or WalkingSpree (Table 1). One hundred fifty-three members (13%)
elected to participate in the WMP, 439 (39%) in Weight Watchers,
and 432 (38%) in WalkingSpree. Only 114 members (10%) chose
not to participate in any of the weight management programs.
The mean age of the 1,138 members was 496 9 years and 53%
were women (Table 1). Patient characteristics were associated with
their choice of program. Members who selected the WMP tended to
be older. Women were more likely to select Weight Watchers and
men were more likely to select WalkingSpree. To remain in the
weight management programs and to maintain enhanced benefits,
members were required to attend 80% of scheduled WMP visits,
11 of 13 weekly Weight Watchers meetings every 3 months, or to
walk an average of 5,000 steps per day in the WalkingSpree pro-
gram every 3 months. Those who failed to meet these requirements
reverted to standard benefits. Program retention was good with 70%
of WMP, 71% of Weight Watchers, and 90% of WalkingSpree par-
ticipants completing 12 months in the programs.
Table 2 shows the characteristics of the study populations before
enrollment and 12 months after enrollment in the programs. At base-
line, mean BMI was 38.36 5.5 kg m22. Systolic and diastolic blood
pressure and HDL and total cholesterol levels were generally well-
controlled. Mean HbA1c (performed for diabetic members) was
7.0%6 1.6% and mean fasting glucose (performed for non-diabetic
members) was 986 26 mg dL21. Six percent of members reported
being treated for depression. At follow-up, there was a 1.3 kg m22
reduction in BMI. For a 5 feet 10 inch tall man with a BMI of 38
kg m22, this would represent a loss of 9 pounds, from 264 pounds
to 255 pounds. For a 5 feet 4 inch tall woman with a BMI of 38 kg
m22, this would represent a loss of 8 pounds, from 221 pounds to
213 pounds. At follow-up, there was also a 0.3% reduction in
HbA1c. Blood pressure, lipids, fasting glucose, and rates of treat-
ment for depression did not change substantially.
When we compared clinical outcomes among members who elected
a program to those who elected no program, it was apparent that
members who elected the WMP demonstrated a consistent and sub-
stantial improvement in all of the risk factors assessed (Table 2).
BMI decreased from 40.46 5.3 kg m22 to 36.26 6.1 kg m22 and
TABLE 1 Characteristics of the study population, N51,138
Characteristic Total WMP Weight Watchers WalkingSpree None
N 1,138 153 (13%) 439 (39%) 432 (38%) 114 (10%)
Age at anchor date (years) 496 9 516 8 506 9 496 9 496 9
Sex (female) 608 (53%) 89 (58%) 286 (65%) 179 (41%) 54 (47%)
Time in program
12 months -- 107 (70%) 313 (71%) 388 (90%) --
Less than 12 months -- 46 (30%) 126 (29%) 44 (10%) --
WMP5University of Michigan Weight Management Program.
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HbA1c decreased from 6.9%6 1.1% to 6.3%6 0.8%. There were
also improvements in systolic and diastolic blood pressure, HDL-
cholesterol, total cholesterol, and fasting glucose. The prevalence of
treated depression, which was initially highest in the WMP popula-
tion, decreased from 13 to 10% at follow-up. Members who elected
Weight Watchers and WalkingSpree showed more modest improve-
ments in BMI and HbA1c, and variable improvements in blood pres-
sure, HDL-cholesterol, and total cholesterol (Table 2). Rates of
treated depression remained unchanged. Members who chose not to
participate in any weight management program showed an
increase in HbA1c and an increase in treated depression at follow-
up (Table 2).
At baseline, per-member per-month (PMPM) direct medical costs,
including both costs paid by the health plan and member copay-
ments, were substantial. Total direct medical costs were $448
PMPM or almost $5,400 per member per year (Table 2). The largest
proportion of costs was attributable to outpatient care and pharmacy.
At baseline, PMPM costs were greatest for members who selected
the WMP ($545 PMPM), lower for those who selected Weight
Watchers ($488 PMPM), lower for those who selected Walking-
Spree ($396 PMPM), and lowest for those who chose not to partici-
pate in any weight management program ($357 PMPM). In multi-
variate analysis adjusting for baseline age, BMI, systolic and
diastolic blood pressure, and HDL and total cholesterol, baseline
PMPM costs tended to be higher for members who chose the WMP
(P5 0.06) but did not differ significantly among the groups. Over
12 months, PMPM costs increased by 13% for the entire population,
from $448 to $506. PMPM costs increased by 7% for those who
selected the WMP, 13% for those who selected Weight Watchers,
12% for those who selected WalkingSpree, and 28% for those who
chose not to participate in any program. After adjusting for baseline
differences in age, BMI, blood pressure, and lipids, PMPM costs
increased by 4% for those who selected the WMP, 10% for those
who selected Weight Watchers, 16% for those who selected Wal-
kingSpree, and 29% for those who chose not to participate in any
program. For members who selected the WMP, Weight Watchers,
and WalkingSpree, the increase in costs was driven largely by the
TABLE 2 Characteristics of the study population before enrollment and 12 months after enrollment in the weight management
programs
Total; N5 1,138 WMP; N5153
Weight
watchers;
N5 439
WalkingSpree;
N5 432 None; N5 114
Characteristic Pre Post Pre Post Pre Post Pre Post Pre Post
BMI (kg m22) 38.36 5.5 37.06 5.8 40.46 5.3 36.26 6.1 39.36 6.0 38.16 6.4 36.46 4.5 35.96 4.6 38.66 5.5 37.96 6.6
Systolic blood pressure
(mmHg) (missing5 4/0)
1266 13 1256 12 1266 12 1226 12 1266 14 1256 13 1256 12 1256 12 1276 15 1276 12
Diastolic blood pressure
(mmHg) (missing5 4/0)
796 8 786 8 796 9 756 8 796 8 786 8 796 8 786 8 806 9 806 7
HDL cholesterol (mg dL21)
(missing5 8/4)
476 13 476 13 466 13 476 13 486 13 486 12 466 13 476 13 446 12 456 11
Total cholesterol (mg dL21)
(missing5 10/13)
1846 35 1816 36 1836 36 1746 37 1846 32 1826 32 1836 36 1806 36 1916 36 1916 40
HbA1c (%) (missing5
913/960)
7.06 1.6 6.76 1.6 6.96 1.1 6.36 0.8 7.06 1.8 6.56 1.3 7.06 1.6 6.76 1.4 7.46 2.1 7.96 2.9
Fasting glucose (mg dL21)
(missing5 486/704)
986 26 966 19 1036 21 976 14 966 24 976 23 966 23 966 16 1066 42 946 16
Treated depression
(missing5 294/46)
54 (6%) 75 (7%) 7 (13%) 14 (10%) 30 (8%) 33 (8%) 16 (4%) 17 (4%) 1 (6%) 11 (15%)
PMPM Costa
Inpatient $71 $87 $112 $79 $71 $103 $60 $76 $60 $74
Outpatient $169 $167 $182 $171 $184 $166 $166 $173 $106 $140
Diagnostic testing $37 $51 $60 $41 $43 $62 $26 $39 $28 $64
Laboratory testing $15 $14 $15 $13 $17 $14 $14 $12 $18 $17
Emergency room $25 $24 $19 $30 $28 $20 $25 $21 $22 $45
Pharmacy $108 $107 $133 $129 $115 $112 $93 $96 $108 $105
Other $21 $57 $24 $119 $30 $74 $12 $29 $15 $12
Total $448 $506 $545 $584 $488 $551 $396 $445 $357 $457
WMP5University of Michigan Weight Management Program
PMPM5per-member per-month
aincludes both plan and member costs.
Missing5 number missing pre/number missing post.
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costs of the programs themselves (included in the “other” category).
Pharmacy costs were largely unchanged. Although the costs of the
WMP were substantially greater than the costs of Weight Watchers
or WalkingSpree, the mean annual cost per unit reduction in BMI
for members who were enrolled for the entire 12-month follow-up
was only $232 for participants in the WMP compared to $380 for
participants in Weight Watchers and $378 for participants in
WalkingSpree.
To more rigorously assess the impact of program participation
on both clinical outcomes and costs, we compared clinical out-
comes and costs within individuals before enrollment and 12
months after enrollment using paired t tests (Table 3). Within
the total population, there were statistically significant improve-
ments in all the clinical outcomes assessed. There was a statisti-
cally significant decrease in the PMPM cost of laboratory test-
ing and an increase in other costs driven primarily by the costs
of the weight management programs themselves. For members
who participated in the WMP, there was improvement in all of
the clinical outcomes assessed. Total PMPM costs increased by
$38. For members who participated in Weight Watchers, there
were improvements in BMI, diastolic blood pressure, and
HbA1c. Total PMPM costs increased by $63. For members who
participated in WalkingSpree, there were improvements in BMI
and total cholesterol. Total PMPM costs increased by $49. For
members who chose not to participate in any weight manage-
ment program, there were improvements in BMI and fasting
glucose. Total PMPM costs increased by $100. After adjusting
for baseline differences in age, BMI, blood pressure and lipids,
total PMPM costs increased by $20 for WMP participants, $49
for Weight Watchers participants, $62 for WalkingSpree partici-
pants and $106 for members who chose not to participate in
any weight management program.
Discussion
In the United States, the prevalence and costs of obesity are enor-
mous and are growing rapidly. Health systems must remove barriers
and provide incentives to encourage the adoption of effective inter-
ventions to prevent and treat obesity. Complimentary societal
TABLE 3 Within individual comparison of risk factor levels and costs before enrollment and 12 months after enrollment in the
weight management programs
Total; N51,138 WMP; N5 153
Weight
watchers; N5 439
WalkingSpree;
N5 432 None; N5 114
Characteristic
Difference
post-pre P value
Difference
post-pre P value
Difference
post-pre P value
Difference
post-pre P value
Difference
post-pre P value
BMI (kg m22) 21.3 <0.0001 24.1 <0.0001 21.2 <0.0001 20.4 <0.0001 20.7 0.0099
Systolic blood
pressure
(mmHg)
21 0.0093 24 0.0017 21 0.0641 0 0.8796 21 0.5534
Diastolic blood
pressure
(mmHg)
21 0.0011 24 <0.0001 21 0.0292 0 0.7851 0 0.7207
HDL cholesterol
(mg dL21)
1 0.0113 2 0.0367 0 0.4002 0 0.2646 1 0.0960
Total cholesterol
(mg dL21)
23 <0.0001 210 0.0003 22 0.0589 23 0.0125 0 0.9539
HbA1c (%) 20.3 0.0055 20.4 0.0445 20.5 0.0126 20.2 0.2713 0.2 0.6848
Fasting glucose
(mg dL21)
22 0.0188 25 0.0066 22 0.4355 0 0.7771 25 0.0300
PMPM costa
Inpatient 15 0.3259 232 0.5113 32 0.2064 15 0.5088 14 0.7719
Outpatient 22 0.8370 211 0.7696 218 0.1899 7 0.7486 35 0.2084
Diagnostic testing 13 0.0874 219 0.0213 19 0.2869 12 0.0032 36 0.1779
Laboratory testing 22 0.0111 21 0.3116 22 0.0572 22 0.1175 21 0.6856
Emergency room 21 0.7849 11 0.2314 28 0.2638 24 0.4342 23 0.0909
Pharmacy 21 0.7816 24 0.7913 23 0.5980 2 0.7243 24 0.5427
Other 36 <0.0001 95 <0.0001 44 <0.0001 17 <0.0001 22 0.6489
Total 58 0.0209 38 0.6154 63 0.0961 49 0.2344 100 0.2397
WMP5University of Michigan Weight Management Program.
PMPM5per-member per-month.
aIncludes both plan and member costs.
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interventions must address education, advertising, food availability
and price, and the built and workplace environments.
One promising approach to obesity treatment comes from the behav-
ioral economic theory of loss aversion (9,10). The theory states that
people make decisions based on the potential value of losses and
gains rather than final outcomes. In general, losses may be a more
powerful motivator than gains. People react powerfully to the threat
of even small financial losses in part because they consider them in
isolation and fail to integrate them into their larger financial pictures.
Loss aversion may thus provide a strong incentive for behavior
change. In this report, we have evaluated the clinical effectiveness
and cost implications of using loss aversion to encourage high-risk
individuals to participate in medical weight management, weight loss,
and physical activity programs. Compared to nonparticipants, individ-
uals who participated demonstrated reductions in body mass index,
improvements in blood pressure, lipid levels, and measures of glyce-
mia, and a lower rate of increase in total PMPM health care costs.
Ninety percent of eligible participants selected one of the three
weight management programs and 79% remained in the program
they selected for at least 1 year. Health plan members were free to
choose the program in which they participated and selection did not
occur at random. Older and more obese patients were more likely to
select the WMP. Women were more likely to select Weight Watch-
ers and men were more likely to select the pedometer-based walking
program. Offering a choice of programs that appeal to different sub-
populations appears to be important for program uptake. Perhaps
due to both the freedom of choice and the financial incentives,
longer-term program participation was also excellent. Members who
did not participate or failed to meet program requirements lost bene-
fits and incurred increased out-of-pocket costs.
Taken as a whole, the target population achieved significant improve-
ments in all of the risk factors assessed. The extent and degree of
improvement were greatest for participants in the WMP, intermediate
for Weight Watchers, and least for WalkingSpree. Improvement in all
groups was greater than for members who chose not to participate.
Although theWMPwas the most expensive, it produced the best clinical
outcomes and was associated with both the smallest percentage increase
and the lowest absolute increase in direct medical costs over 1 year. In
the Look AHEAD study, weight loss in the first year was the strongest
predictor of sustained weight loss at year 4 (11). This suggests that with
continued reinforcement, theWMPmay have the most sustained impact.
Although no program was cost-saving, in large part due to the program
costs themselves, all programs cost only $230 to $380 per unit reduction
in BMI over 1 year. For patients who participated in any weight manage-
ment program, total PMPMdirect medical costs increased by only $38 to
$63. Over 1 year, this increase in total PMPM cost was less than for
members who chose not to participate in any weight management pro-
gram ($100 increase in total PMPM costs).
There were a number of limitations to our study. The study was not
a randomized, controlled, clinical trial. Patients’ clinical characteris-
tics and preferences clearly influenced their choice of programs and
may have impacted their outcomes. The fact that more patients who
chose not to participate in any weight management program were
identified as having treated depression at follow-up suggests that
mental health issues may have been more frequent among nonparti-
cipants. Second, the clinical outcomes assessed including BMI may
not have fully captured the health benefits of the interventions, espe-
cially the pedometer-based walking program. Third, PMPM costs
were based on health plan administrative data and did not include
out-of-plan costs. In an insured population, it is unlikely that such
costs would have been substantial.
In summary, we have demonstrated that a managed care benefit
structure that offered a variety of weight management programs to
obese members, and financially penalized those who did not partici-
pate resulted in a 90% program uptake and 79% 1-year retention.
Program participation was associated with significant reductions in
BMI and improvements in cardiovascular risk factors including
blood pressure, lipids, and glycemia with no increase in pharmacy
costs. Although not cost-saving, this benefit design and behavioral
economic approach employing loss aversion reduced the rate of
increase in direct medical costs over 1 year and appeared to be cost-
effective, providing good value for money. With extended follow-
up, the observed reductions in BMI and cardiovascular risk factors
may translate into cost-savings.O
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